Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

From impact factors to real impact: translating evidence on lifestyle interventions into routine mental health care.

Deenik J, Czosnek L, Teasdale SB, Stubbs B, Firth J, Schuch FB, Tenback DE, van Harten PN, Tak ECPM, Lederman O, Ward PB, Hendriksen IJM, Vancampfort D, Rosenbaum S.

Transl Behav Med. 2019 Jun 6. pii: ibz067. doi: 10.1093/tbm/ibz067. [Epub ahead of print]

PMID:
31169897
2.

Less Medication Use in Inpatients With Severe Mental Illness Receiving a Multidisciplinary Lifestyle Enhancing Treatment. The MULTI Study III.

Deenik J, Tenback DE, van Driel HF, Tak ECPM, Hendriksen IJM, van Harten PN.

Front Psychiatry. 2018 Dec 18;9:707. doi: 10.3389/fpsyt.2018.00707. eCollection 2018.

3.

Changes in physical and psychiatric health after a multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: The MULTI study I.

Deenik J, Tenback DE, Tak ECPM, Rutters F, Hendriksen IJM, van Harten PN.

Schizophr Res. 2019 Feb;204:360-367. doi: 10.1016/j.schres.2018.07.033. Epub 2018 Jul 25.

4.

Instrumental measurements of spontaneous dyskinesia and schizotypy in subjects with auditory verbal hallucinations and healthy controls.

Willems AE, Sommer IE, Tenback DE, Koning JP, van Harten PN.

Psychiatry Res. 2016 Oct 30;244:24-7. doi: 10.1016/j.psychres.2016.06.028. Epub 2016 Jul 7.

PMID:
27455147
5.

Movement Disorders in Adults With Intellectual Disability and Behavioral Problems Associated With Use of Antipsychotics.

Scheifes A, Walraven S, Stolker JJ, Nijman HL, Tenback DE, Egberts TC, Heerdink ER.

J Clin Psychopharmacol. 2016 Aug;36(4):308-13. doi: 10.1097/JCP.0000000000000528.

PMID:
27300250
6.

Reliability and validity of an instrument for the assessment of bradykinesia.

Mentzel TQ, Lieverse R, Levens A, Mentzel CL, Tenback DE, Bakker PR, Daanen HAM, van Harten PN.

Psychiatry Res. 2016 Apr 30;238:189-195. doi: 10.1016/j.psychres.2016.02.011. Epub 2016 Feb 17.

7.

The Relation between Psychiatric Diagnoses and Constipation in Hospitalized Patients: A Cross-Sectional Study.

Jessurun JG, van Harten PN, Egberts TC, Pijl YJ, Wilting I, Tenback DE.

Psychiatry J. 2016;2016:2459693. doi: 10.1155/2016/2459693. Epub 2016 Mar 10.

8.

[Severe treatment-resistant tardive dystonia: is deep brain stimulation a treatment option].

Mentzel CL, Tenback DE, Tijssen MA, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):125-31. Dutch.

9.

[Risk factors for tardive movement disorders in schizophrenia].

Tenback DE, Bakker PR, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):120-4. Review. Dutch.

10.

Movement disorders and psychosis, a complex marriage.

van Harten PN, Bakker PR, Mentzel CL, Tijssen MA, Tenback DE.

Front Psychiatry. 2015 Jan 9;5:190. doi: 10.3389/fpsyt.2014.00190. eCollection 2014. Review. No abstract available.

11.

Acute movement disorders associated with the use of second-generation antipsychotics in borderline personality disorder: a meta-analysis.

Willems AE, Tenback DE, Ingenhoven TJ, van Harten PN.

J Clin Psychopharmacol. 2014 Aug;34(4):520-2. doi: 10.1097/JCP.0000000000000152. No abstract available.

PMID:
24911435
12.

The effect of psychotropic medications on the occurrence of constipation in hospitalized psychiatric patients.

Jessurun JG, van Harten PN, Egberts TC, Pijl BJ, Wilting I, Tenback DE.

J Clin Psychopharmacol. 2013 Aug;33(4):587-90. doi: 10.1097/JCP.0b013e318299d2bd. No abstract available.

PMID:
23775058
13.

[Risk factors for inactivity in patients in long-term care with severe mental illness].

Tenback DE, van Kessel F, Jessurun J, Pijl YJ, Heerdink ER, van Harten PN.

Tijdschr Psychiatr. 2013;55(2):83-91. Dutch.

14.

Efficacy and safety of deep brain stimulation in patients with medication-induced tardive dyskinesia and/or dystonia: a systematic review.

Mentzel CL, Tenback DE, Tijssen MA, Visser-Vandewalle VE, van Harten PN.

J Clin Psychiatry. 2012 Nov;73(11):1434-8. doi: 10.4088/JCP.12r07643. Review.

PMID:
23218160
15.

Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.

Roke Y, van Harten PN, Buitelaar JK, Tenback DE, Quekel LG, de Rijke YB, Boot AM.

Eur J Endocrinol. 2012 Dec;167(6):855-63. doi: 10.1530/EJE-12-0521. Epub 2012 Sep 25.

PMID:
23011870
16.

Antipsychotic-induced hyperprolactinemia and testosterone levels in boys.

Roke Y, van Harten PN, Buitelaar JK, Tenback DE, de Rijke YB, Boot AM.

Horm Res Paediatr. 2012;77(4):235-40. doi: 10.1159/000337910. Epub 2012 Apr 26.

PMID:
22538969
17.

Epidemiology and risk factors for (tardive) dyskinesia.

Tenback DE, van Harten PN.

Int Rev Neurobiol. 2011;98:211-30. doi: 10.1016/B978-0-12-381328-2.00009-2. Review.

PMID:
21907089
18.

Tardive dyskinesia: clinical presentation and treatment.

van Harten PN, Tenback DE.

Int Rev Neurobiol. 2011;98:187-210. doi: 10.1016/B978-0-12-381328-2.00008-0. Review.

PMID:
21907088
19.

Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis.

Koning JP, Tenback DE, Kahn RS, Vollema MG, Cahn W, van Harten PN.

Psychol Med. 2011 Oct;41(10):2141-7. doi: 10.1017/S0033291711000389. Epub 2011 Mar 22.

PMID:
21426602
20.

Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis.

Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN.

Psychiatry Res. 2011 Jun 30;188(1):133-7. doi: 10.1016/j.psychres.2011.01.005. Epub 2011 Jan 31.

PMID:
21277026

Supplemental Content

Loading ...
Support Center